ASH 2017: CAR T-Cell Therapy

Separating Hype from Hope About CAR T-Cell Therapy News 

The big buzz at the American Society of Hematology (ASH) annual meeting in Atlanta, which ended Tuesday, surrounded the presentations of CAR T-cell therapy clinical trial data. But the excitement, says IMF Chairman Dr. Brian G.M. Durie, is tempered by medical concerns. “From a medical standpoint, results in the CAR T-cell trials were very similar to what we have seen for several years: Small studies with some evidence of deep responses, but definite concerns about serious toxicities.” Read Dr. Durie’s blog.

 

Highlights From the IMF at the 2017 American Society of Hematology (ASH) Annual Meeting

Braving unseasonably cold temperatures and snow, IMF-affiliated researchers, patients, support group leaders, and caregivers sought the latest myeloma news presented at the 59th annual meeting of the American Society of Hematology (ASH.) From research grant award dinners to new insights in the field of myeloma to heartfelt patient experiences blogged live from the event, the IMF’s presence at #ASH17 was tremendous. We invite you to take part in all of last weekend’s events at our ASH Highlights webpage.

 

FDA Lifts Hold on Clinical Trials for the Use of Opdivo (nivolumab)-based Combinations for Myeloma

The U.S. Food and Drug Administration will now allow two clinical trials of Opdivo-based combinations for myeloma to begin, after placing these trials on partial hold earlier this year. The two trials that will now be able to begin are the phase I CheckMate -039 (NCT01592370) and a phase II CA204142 (NCT02612779) study. Both of these trials study the use of Opdivo-based combinations in patients with relapsed or refractory multiple myeloma.

Register NOW for This IMF Regional Community Workshop in Raleigh, North Carolina

The IMF will host a Regional Community Workshop in Raleigh, North Carolina, on February 3, 2018. Registration is FREE, but seating is limited. Here’s your chance to learn from and meet one-on-one with myeloma experts Dr. Rafat Abonour (Indiana University Simon Cancer Center) and Dr. Cristina Gasparetto (Duke University Duke Cancer Institute). 

What should we have for dinner during the holidays?

In this week’s video, Dr. Brian G.M. Durie gives a light-hearted talk on how to enjoy the holidays without over-indulging.

This weekly newsletter is supported from funds by donors like you. Donate to continue to make publications like this one possible.

We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology